Tag «Chittaranjan National Cancer Institute»

QIAGEN launches careHPVTM Test in India – to expand preventive screening against cervical cancer

The careHPVTM Test is the first HPV diagnostic designed for regions with limited healthcare infrastructure, complementing QIAGEN’s market-leading digene HC2 HPV Test   Commercial launch of careHPV Test in India enables high–quality screening for prevention of cervical cancer among women in low-resource areas   The careHPV Test plays an important role in QIAGEN’s Corporate Social …